Sherry Aulin

Insider Reports History

Entity
Individual
Location
200 3650 Gilmore Way, Burnaby, Alberta, Canada
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sherry Aulin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Chief Financial Officer Stock Option (Right to Buy) 100K Mar 11, 2024 Direct

Insider Reports Filed by Sherry Aulin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XENE Xenon Pharmaceuticals Inc. Mar 11, 2024 1 $0 4 Mar 12, 2024 Chief Financial Officer
XENE Xenon Pharmaceuticals Inc. Mar 10, 2023 1 $0 4 Mar 14, 2023 Chief Financial Officer
XENE Xenon Pharmaceuticals Inc. Sep 2, 2022 12 -$608K 4 Sep 7, 2022 Chief Financial Officer
XENE Xenon Pharmaceuticals Inc. Mar 10, 2022 1 $0 4 Mar 14, 2022 Chief Financial Officer
XENE Xenon Pharmaceuticals Inc. Jun 3, 2021 1 $0 4 Jun 3, 2021 Chief Financial Officer
XENE Xenon Pharmaceuticals Inc. Jun 3, 2021 0 $0 3 Jun 3, 2021 Chief Financial Officer